Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1933277

Cover Image

PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1933277

Digital Pathology Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034

PUBLISHED:
PAGES: 149 Pages
DELIVERY TIME: Inquiry
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4850
Unprintable PDF & Excel (Multi User License)
USD 5850
PDF, Excel & PPT (Enterprise License)
USD 6850

Add to Cart

Growth Factors of digital pathology Market

The global digital pathology market is witnessing rapid growth, driven by the rising prevalence of chronic diseases, increased hospital admissions, and the growing adoption of digital tools in traditional pathology workflows. Digital pathology involves creating digital slides through whole-slide scanning devices or digital microscopes, which can then be analyzed using high-throughput algorithms, shared remotely, or stored for future reference. These innovations have transformed modern diagnostics, enabling faster and more accurate analysis while reducing workload for pathologists.

According to Fortune Business Insights, the market was valued at USD 1.3 billion in 2025, projected to grow to USD 1.47 billion in 2026, and estimated to reach USD 5.75 billion by 2034, reflecting a CAGR of 18.56% from 2026 to 2034. North America dominated the market in 2025 with a 36.74% share, led by robust digital infrastructure, early adoption of AI-powered pathology solutions, and high awareness of advanced diagnostics. In the U.S., the digital pathology market is projected to reach USD 1.30 billion by 2032, supported by increasing digitization and favorable FDA policies for remote review and analysis of digital slides.

Market Drivers

Rising Burden of Chronic Diseases: The increasing incidence of chronic conditions and hospitalizations is boosting demand for timely and accurate pathology tests. Studies indicate that digitization enhances efficiency, with pathologists reporting a 15% productivity increase compared to traditional workflows. Additionally, digital platforms are increasingly used for predictive analysis and early diagnosis of diseases, such as Parkinson's disease, further stimulating market growth.

COVID-19 Impact: The pandemic accelerated digital adoption in pathology due to reduced in-person consultations and emergency regulatory approvals. The U.S. FDA implemented policies in April 2020 allowing remote reviewing of digital slides. The market saw a 31.2% growth in 2020, compared to 11.6% in 2019, driven by telepathology and remote diagnostics. Post-pandemic, patient volumes returned to pre-pandemic levels, but adoption of digital solutions remained high, sustaining growth momentum.

Integration of Artificial Intelligence: AI-based digital tools are transforming pathology by enabling advanced image analysis, workflow management, and deep learning-based diagnostics. For example, Roche launched AI algorithms in December 2021 for breast cancer marker evaluation, and Sigtuple received FDA approval in September 2023 for its AI-assisted blood smear application. Such advancements improve diagnostic accuracy and operational efficiency.

Market Restraints

High Upfront Costs: The installation of digital pathology systems, including high-throughput scanners, software, and storage solutions, involves substantial investment. Digital slide scanners range from USD 100,000 to USD 400,000, excluding costs for training, technical support, and licensing. Smaller laboratories often struggle to afford these tools, which limits market penetration. Additionally, the shortage of pathologists, with a net deficit of 5,700 per 100,000 population, further hinders adoption in certain regions.

Market Segmentation

By Product Type:

  • Hardware: Dominates with 58.10% share in 2026, driven by demand for scanners and tissue microarrayers for timely pathology outcomes.
  • Software: Holds 35.2% share in 2024, fueled by AI-based image analysis, pathology management, and digital microscopy viewers.
  • Storage Systems: Supporting growth due to the need for secure data storage and sharing.

By Application:

  • Disease Diagnosis: Leading segment with 54.96% market share in 2026, driven by rising diagnostic testing requirements and early detection initiatives.
  • Drug Discovery: Growing rapidly due to high-throughput screening and demand for pipeline drugs.

By End User:

  • Hospitals & Clinics: Dominant with 62.18% share in 2026, supported by rising patient admissions and adoption of AI-assisted digital pathology systems.
  • Clinical Laboratories: Expanding segment due to digitization of slides and collaborative AI-driven solutions.

Regional Insights

North America: Market size USD 0.48 billion in 2025, projected at USD 0.5 billion by 2026, driven by high chronic disease prevalence, geriatric population, and workflow digitization initiatives.

Europe: Second-largest market, supported by technological advancements, regulatory approvals, and AI-based solutions. The UK market is projected at USD 0.05 billion by 2026, and Germany at USD 0.11 billion by 2026.

Asia Pacific: Fastest-growing region due to expanding healthcare infrastructure, public and private investments, and increasing patient volumes. Japan is projected at USD 0.09 billion, China at USD 0.07 billion, and India at USD 0.05 billion by 2026.

Latin America & Middle East & Africa: Steady growth is driven by medical tourism, healthcare investments, and adoption of digital pathology tools.

Key Players & Industry Developments

Prominent companies include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Hamamatsu Photonics K.K., 3DHISTECH Ltd., Koninklijke Philips N.V., Apollo Enterprise Imaging Corp., Sectra AB, and Huron Technologies.

Recent Developments:

  • February 2024: Roche partnered with PathAI to develop AI algorithms for tissue diagnostics.
  • October 2023: Roche collaborated with Ibex and AWS for AI-enabled breast and prostate cancer diagnostics.
  • August 2023: PathAI launched AISight Digital Pathology Image Management System.
  • April 2022: 3DHISTECH deployed digital pathology tools across 8 hospitals in Spain.

Conclusion

The global digital pathology market is projected to grow from USD 1.3 billion in 2025 to USD 1.47 billion in 2026, reaching USD 5.75 billion by 2034 at a CAGR of 18.56%. Market growth is driven by increasing chronic disease burden, digitization of pathology workflows, integration of AI, and rising adoption of high-throughput diagnostic tools. Despite challenges like high upfront costs and shortage of pathologists, ongoing technological advancements, regulatory support, and strategic partnerships by key players are expected to sustain the market's robust growth globally.

Segmentation By Product

  • Hardware
    • Scanners
    • Tissue Microarrayer
    • Others
  • Software
    • Pathology Management
    • Digital Microscopy Viewers
    • Image Analyzers
    • Others
  • Storage Systems

By Application

  • Disease Diagnosis
  • Drug Discovery
  • Others

By End-user

  • Hospitals & Clinics
  • Clinical Laboratories
  • Others

By Geography

  • North America (By Product, Application, End-user, and Country)
    • U.S.
    • Canada
  • Europe (By Product, Application, End-user, and Country/Sub-Region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product, Application, End-user, and Country/Sub-Region)
    • China
    • India
    • Japan
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product, Application, End-user, and Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product, Application, End-user, and Country/Sub-Region)
    • GCC
    • South Africa
  • Rest of Middle East & Africa
Product Code: FBI100229

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Key Industry Developments- Mergers, Acquisitions and Partnerships
  • 4.2. Technological Advancements in Digital Pathology
  • 4.3. Snapshot: Global Digital Health Market, 2024
  • 4.4. Impact of COVID-19 on the Market

5. Global Digital Pathology Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product
    • 5.1.1. Hardware
      • 5.1.1.1. Scanners
      • 5.1.1.2. Tissue Microarrayer
      • 5.1.1.3. Others
    • 5.1.2. Software
      • 5.1.2.1. Pathology Management
      • 5.1.2.2. Digital Microscopy Viewers
      • 5.1.2.3. Image Analyzers
      • 5.1.2.4. Others
    • 5.1.3. Storage Systems
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Disease Diagnosis
    • 5.2.2. Drug Discovery
    • 5.2.3. Others
  • 5.3. Market Analysis, Insights and Forecast - By End User
    • 5.3.1. Hospitals & Clinics
    • 5.3.2. Clinical Laboratories
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Digital Pathology Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product
    • 6.1.1. Hardware
      • 6.1.1.1. Scanners
      • 6.1.1.2. Tissue Microarrayer
      • 6.1.1.3. Others
    • 6.1.2. Software
      • 6.1.2.1. Pathology Management
      • 6.1.2.2. Digital Microscopy Viewers
      • 6.1.2.3. Image Analyzers
      • 6.1.2.4. Others
    • 6.1.3. Storage Systems
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Disease Diagnosis
    • 6.2.2. Drug Discovery
    • 6.2.3. Others
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Hospitals & Clinics
    • 6.3.2. Clinical Laboratories
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Digital Pathology Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product
    • 7.1.1. Hardware
      • 7.1.1.1. Scanners
      • 7.1.1.2. Tissue Microarrayer
      • 7.1.1.3. Others
    • 7.1.2. Software
      • 7.1.2.1. Pathology Management
      • 7.1.2.2. Digital Microscopy Viewers
      • 7.1.2.3. Image Analyzers
      • 7.1.2.4. Others
    • 7.1.3. Storage Systems
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Disease Diagnosis
    • 7.2.2. Drug Discovery
    • 7.2.3. Others
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Hospitals & Clinics
    • 7.3.2. Clinical Laboratories
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific Digital Pathology Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product
    • 8.1.1. Hardware
      • 8.1.1.1. Scanners
      • 8.1.1.2. Tissue Microarrayer
      • 8.1.1.3. Others
    • 8.1.2. Software
      • 8.1.2.1. Pathology Management
      • 8.1.2.2. Digital Microscopy Viewers
      • 8.1.2.3. Image Analyzers
      • 8.1.2.4. Others
    • 8.1.3. Storage Systems
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Disease Diagnosis
    • 8.2.2. Drug Discovery
    • 8.2.3. Others
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Hospitals & Clinics
    • 8.3.2. Clinical Laboratories
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Digital Pathology Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product
    • 9.1.1. Hardware
      • 9.1.1.1. Scanners
      • 9.1.1.2. Tissue Microarrayer
      • 9.1.1.3. Others
    • 9.1.2. Software
      • 9.1.2.1. Pathology Management
      • 9.1.2.2. Digital Microscopy Viewers
      • 9.1.2.3. Image Analyzers
      • 9.1.2.4. Others
    • 9.1.3. Storage Systems
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Disease Diagnosis
    • 9.2.2. Drug Discovery
    • 9.2.3. Others
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Hospitals & Clinics
    • 9.3.2. Clinical Laboratories
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Digital Pathology Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product
    • 10.1.1. Hardware
      • 10.1.1.1. Scanners
      • 10.1.1.2. Tissue Microarrayer
      • 10.1.1.3. Others
    • 10.1.2. Software
      • 10.1.2.1. Pathology Management
      • 10.1.2.2. Digital Microscopy Viewers
      • 10.1.2.3. Image Analyzers
      • 10.1.2.4. Others
    • 10.1.3. Storage Systems
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Disease Diagnosis
    • 10.2.2. Drug Discovery
    • 10.2.3. Others
  • 10.3. Market Analysis, Insights and Forecast - By End User
    • 10.3.1. Hospitals & Clinics
    • 10.3.2. Clinical Laboratories
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 10.4.1. GCC Countries
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2024)
  • 11.2. Company Profiles
    • 11.2.1. Leica Biosystems Nussloch GmbH
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT analysis
      • 11.2.1.4. Recent developments
      • 11.2.1.5. strategies
      • 11.2.1.6. financials (based on availability)
    • 11.2.2. Thermo Fisher Scientific Inc.
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT analysis
      • 11.2.2.4. Recent developments
      • 11.2.2.5. strategies
      • 11.2.2.6. financials (based on availability)
    • 11.2.3. F. Hoffmann-La Roche Ltd
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT analysis
      • 11.2.3.4. Recent developments
      • 11.2.3.5. strategies
      • 11.2.3.6. financials (based on availability)
    • 11.2.4. Hamamatsu Photonics K.K.
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT analysis
      • 11.2.4.4. Recent developments
      • 11.2.4.5. strategies
      • 11.2.4.6. financials (based on availability)
    • 11.2.5. Akoya Biosciences, Inc.
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT analysis
      • 11.2.5.4. Recent developments
      • 11.2.5.5. strategies
      • 11.2.5.6. financials (based on availability)
    • 11.2.6. 3DHISTECH Ltd.
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT analysis
      • 11.2.6.4. Recent developments
      • 11.2.6.5. strategies
      • 11.2.6.6. financials (based on availability)
    • 11.2.7. Koninklijke Philips N.V.
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT analysis
      • 11.2.7.4. Recent developments
      • 11.2.7.5. strategies
      • 11.2.7.6. financials (based on availability)
    • 11.2.8. Apollo Enterprise Imaging Corp
      • 11.2.8.1. Overview
      • 11.2.8.2. Products
      • 11.2.8.3. SWOT analysis
      • 11.2.8.4. Recent developments
      • 11.2.8.5. strategies
      • 11.2.8.6. financials (based on availability)
    • 11.2.9. Sectra AB
      • 11.2.9.1. Overview
      • 11.2.9.2. Products
      • 11.2.9.3. SWOT analysis
      • 11.2.9.4. Recent developments
      • 11.2.9.5. strategies
      • 11.2.9.6. financials (based on availability)
    • 11.2.10. Huron Technologies International Inc.
      • 11.2.10.1. Overview
      • 11.2.10.2. Products
      • 11.2.10.3. SWOT analysis
      • 11.2.10.4. Recent developments
      • 11.2.10.5. strategies
      • 11.2.10.6. financials (based on availability)
Product Code: FBI100229

List of Tables

  • Table 1: Global Digital Pathology Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 2: Global Digital Pathology Market Revenue (USD billion) Forecast, by Hardware, 2021-2034
  • Table 3: Global Digital Pathology Market Revenue (USD billion) Forecast, by Software, 2021-2034
  • Table 4: Global Digital Pathology Market Revenue (USD billion) Forecast, by Applications, 2021-2034
  • Table 5: Global Digital Pathology Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 6: Global Digital Pathology Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 7: North America Digital Pathology Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 8: North America Digital Pathology Market Revenue (USD billion) Forecast, by Hardware, 2021-2034
  • Table 9: North America Digital Pathology Market Revenue (USD billion) Forecast, by Software, 2021-2034
  • Table 10: North America Digital Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 11: North America Digital Pathology Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 12: North America Digital Pathology Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 13: Europe Digital Pathology Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 14: Europe Digital Pathology Market Revenue (USD billion) Forecast, by Hardware, 2021-2034
  • Table 15: Europe Digital Pathology Market Revenue (USD billion) Forecast, by Software, 2021-2034
  • Table 16: Europe Digital Pathology Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 17: Europe Digital Pathology Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 18: Asia Pacific Digital Pathology Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 19: Asia Pacific Digital Pathology Market Revenue (USD billion) Forecast, by Hardware, 2021-2034
  • Table 20: Asia Pacific Digital Pathology Market Revenue (USD billion) Forecast, by Software, 2021-2034
  • Table 21: Asia Pacific Digital Pathology Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 22: Asia Pacific Digital Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 23: Asia Pacific Digital Pathology Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 24: Latin America Digital Pathology Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 25: Latin America Digital Pathology Market Revenue (USD billion) Forecast, by Hardware, 2021-2034
  • Table 26: Latin America Digital Pathology Market Revenue (USD billion) Forecast, by Software, 2021-2034
  • Table 27: Latin America Digital Pathology Market Revenue (USD billion) Forecast, by Applications, 2021-2034
  • Table 28: Latin America Digital Pathology Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 29: Latin America Digital Pathology Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 30: Middle East & Africa Digital Pathology Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 31: Middle East & Africa Digital Pathology Market Revenue (USD billion) Forecast, by Hardware, 2021-2034
  • Table 32: Middle East & Africa Digital Pathology Market Revenue (USD billion) Forecast, by Software, 2021-2034
  • Table 33: Middle East & Africa Digital Pathology Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 34: Middle East & Africa Digital Pathology Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 35: Middle East & Africa Digital Pathology Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Digital Pathology Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Digital Pathology Market Value Share (%), by Product, 2025 & 2034
  • Figure 3: Global Digital Pathology Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Digital Pathology Market Value Share (%), by End-user, 2025 & 2034
  • Figure 5: Global Digital Pathology Market Value (USD billion), by Region, 2025 & 2034
  • Figure 6: North America Digital Pathology Market Value (USD billion), by Product, 2025 & 2034
  • Figure 7: North America Digital Pathology Market Value Share (%), by Product, 2024
  • Figure 8: North America Digital Pathology Market Value (USD billion), by Application, 2025 & 2034
  • Figure 9: North America Digital Pathology Market Value Share (%), by Application, 2024
  • Figure 10: North America Digital Pathology Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 11: North America Digital Pathology Market Value Share (%), by End-user, 2024
  • Figure 12: North America Digital Pathology Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Digital Pathology Market Value Share (%), By Country, 2024
  • Figure 14: Europe Digital Pathology Market Value (USD billion), by Product, 2025 & 2034
  • Figure 15: Europe Digital Pathology Market Value Share (%), by Product, 2024
  • Figure 16: Europe Digital Pathology Market Value (USD billion), by Application, 2025 & 2034
  • Figure 17: Europe Digital Pathology Market Value Share (%), by Application, 2024
  • Figure 18: Europe Digital Pathology Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 19: Europe Digital Pathology Market Value Share (%), by End-user, 2024
  • Figure 20: Europe Digital Pathology Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Digital Pathology Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 22: Asia Pacific Digital Pathology Market Value (USD billion), by Product, 2025 & 2034
  • Figure 23: Asia Pacific Digital Pathology Market Value Share (%), by Product, 2024
  • Figure 24: Asia Pacific Digital Pathology Market Value (USD billion), by Application, 2025 & 2034
  • Figure 25: Asia Pacific Digital Pathology Market Value Share (%), by Application, 2024
  • Figure 26: Asia Pacific Digital Pathology Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 27: Asia Pacific Digital Pathology Market Value Share (%), by End-user, 2024
  • Figure 28: Asia Pacific Digital Pathology Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Digital Pathology Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 30: Latin America Digital Pathology Market Value (USD billion), by Product, 2025 & 2034
  • Figure 31: Latin America Digital Pathology Market Value Share (%), by Product, 2024
  • Figure 32: Latin America Digital Pathology Market Value (USD billion), by Application, 2025 & 2034
  • Figure 33: Latin America Digital Pathology Market Value Share (%), by Application, 2024
  • Figure 34: Latin America Digital Pathology Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 35: Latin America Digital Pathology Market Value Share (%), by End-user, 2024
  • Figure 36: Latin America Digital Pathology Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Digital Pathology Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 38: Middle East & Africa Digital Pathology Market Value (USD billion), by Product, 2025 & 2034
  • Figure 39: Middle East & Africa Digital Pathology Market Value Share (%), by Product, 2024
  • Figure 40: Middle East & Africa Digital Pathology Market Value (USD billion), by Application, 2025 & 2034
  • Figure 41: Middle East & Africa Digital Pathology Market Value Share (%), by Application, 2024
  • Figure 42: Middle East & Africa Digital Pathology Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 43: Middle East & Africa Digital Pathology Market Value Share (%), by End-user, 2024
  • Figure 44: Middle East & Africa Digital Pathology Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Digital Pathology Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 46: Global Digital Pathology Market Share (%), By Company, 2024
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!